Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $247,210 - $511,530
-29,500 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $173,290 - $288,300
-15,500 Reduced 34.44%
29,500 $528,000
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $544,050 - $920,700
45,000 New
45,000 $562,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $527M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.